Navigating the Genomic Labyrinth: The Complexities, Clinical Trials, and Future Frontiers of HRD Testing in Ovarian Cancer
Executive Overview Testing for homologous recombination deficiency (HRD) has emerged as a cornerstone of personalized oncology, particularly in the management...
